Superworth

Embecta EV/EBIT EMBC

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2022.

Today, Nov 2, 2026
6.6×
4-year median
8.8×
Against its 4-year history
19th
percentile: 0 is its lowest day, 100 its highest
4-year range
4.8× to 14.4×
Peer median
18.5×

Embecta's EV/EBIT is 6.6× as of Nov 2, 2026.

That is below its 4-year median of 8.8×, lower than on 81% of days in the last 4 years.

Over that time it ranged from 4.8× in Jun 2026 to 14.4× in Dec 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 18.5×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far6.6×4.8×6.9×
20256.8×6.7×14.3×
202414.4×9.9×14.4×
202310.4×7.0×10.4×
20227.4×7.4×7.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest Embecta's size, closest first, today.

Where Embecta ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Embecta

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.